Skip to main content
VYNE Therapeutics Inc. logo

VYNE Therapeutics Inc. — Investor Relations & Filings

Ticker · VYNE ISIN · US92941V1008 US Manufacturing
Open in API
Filings indexed 607 across all filing types
Latest filing 2025-05-08 Earnings Release
Country US United States of America
Listing US VYNE

About VYNE Therapeutics Inc.

https://vynetherapeutics.com/

VYNE Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing proprietary and differentiated therapies for the treatment of immuno-inflammatory conditions. The company's primary objective is to address unmet medical needs by advancing a pipeline of novel drug candidates. VYNE's approach centers on innovating beyond traditional assumptions to find improved solutions for patients with complex inflammatory and immunological diseases.

Recent filings

Filing Released Lang Actions
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events. The key content is in Item 2.02, which states that the company issued a press release announcing its financial results for the quarter ended March 31, 2025. The actual financial results are in the press release (Exhibit 99.1), which is attached but not fully included here. The Form 8-K itself does not contain detailed financial statements or substantive financial data, only a reference to the press release. According to the rules, a document that primarily announces or furnishes a press release with financial results but does not contain the full financial data should be classified as an Earnings Release (ER) if it is the initial announcement of quarterly financial results. Since this is a quarterly result announcement, it fits the Earnings Release category. The document length is under 5,000 characters but it is not merely announcing the report's publication; it is the actual filing of the earnings announcement. Therefore, the correct classification is ER with high confidence.
2025-05-08 English
Director's Dealing 2025
Director's Dealing
2025-04-02 English
Director's Dealing 2025
Director's Dealing
2025-04-02 English
Director's Dealing 2025
Director's Dealing
2025-04-02 English
Director's Dealing 2025
Director's Dealing
2025-04-02 English
10-K
Annual Report FY 2024
2025-03-06 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.